Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
All this good news is killing the price.
14 years and waiting
buzzlite,
thank you, thank you, thank you!
i appreciate you taking the time to share your dd with the group :)
it's so nice to see progress and a p.o. with units planned to be shipped.
thanks again!
glty & glta!
Found this nugget today.
Low flower $ALRTF ($0.03) launching Pet CGM in Canada Aug 28th with $700,000 sale value for first order
$ALRTF has a float of 163,000,000 and trades on the higher OTC.QB tier which means they are fully SEC reporting. The CEO and his family basically own the rest of the O/S with restricted shares so he doesnt make money unless we shareholders make money. No toxic dilution in the history of the company.
Today they just announced they are starting sales for their one of a kind pet CGM for diabetic dogs and cats in Canada on August 28th, their initial purchase order of inventory carries a sales value of $600k-$700k. ALRT also partnered with a company called Covetrus who was just bought out and taken private for $4 billion, the PR mentions that they up upgrading to an even newer model CGM and will relaunch with Covetrus in the US and EU in Q4.
Regarding the product itself, diabetic dogs and cats can't be monitored like humans because you can't prick their fingers with a lancet to test. You can only draw blood from a vein in their ear/paw with a lancet and it is very difficult to do. To monitor their diabetes they get dropped off at a vet clinic for 12 hours and the vet draws blood with a needed every 2 hours to make a glucose curve graph that shows how their blood sugar is doing over the 12 hour course of insulin.
Since that method delivers so few readings, inaccuracies from stress, and is costly, instead veterinarians have been prescribing the human CGM Libre 2 to monitor diabetes in pets. But because it requires a prescription vets cant make money off it and the pet owner has to make a 2nd appointment to come back and have it applied. Also the company that makes Libre does not support it for animal use and there are tons of problems with the hardware and software.
That being said, I am very confident the GluCurve Pet CGM will be a huge success, according to ALRT there are 75,000+ diabetic dogs and cats in Canada, nearly 1 million in the USA, and nearly 1 million in the EU. The market is huge and the market is desperate for a solution.
Yes, volume is very low but that will change very soon in my opinion. Also, you have to use a real broker to buy/sell shares of ALRTF its not available on robinhood.
News! GluCurve-Pet-CGM Canadian launch Aug-28th, $700,000 sales value on first order! News on the website and a few PR scanners now, should hit all the wires soon.
ALR Technologies Announces Canadian Launch Plans for the GluCurve Pet CGM
(August 7th, 2023 -- Singapore) ALR Technologies SG Ltd. (“ALRT” or the “Company”) (OTCQB:ALRTF), the diabetes management company, announces plans to launch the GluCurve Pet CGM (“GluCurve”) in Canada during Q3 2023 with a direct to veterinarian clinic sales model through GluCurve.ca. The Canadian website will go live on or before August 28th when the Company expects to begin taking orders. The inventory from the purchase order announced on June 1, 2023 will now be used for the Canadian launch. The quantity of units ordered has been increased and delivery will be spread out between August through October with a projected sales value of $600,000-$700,000.
“We are extremely excited to launch the GluCurve Pet CGM for the estimated 75,000+ diabetic cats and dogs in Canada,” said Joe Stern Head of Animal Health at ALR Technologies SG Ltd. “The Canadian veterinary market is a unique landscape that does not use distributors like the US or EU, providing us the opportunity to sell direct to clinics at very favorable margins. Between the size and nature of the market, and the significant interest we have received from Canadian veterinarians, the decision to supply the GluCurve to Canada was obvious.”
The Company’s CGM hardware supplier is finalizing and converting manufacturing from their 1st generation all-in-one model CGM previously referenced in ALRT’s June 1, 2023 press release, to a 2nd generation all-in-one model CGM expected to be ready for use in Q4 2023 for GluCurve. During this transition, an interim two piece model consisting of a separate sensor and Bluetooth transmitter will be made available in limited quantities to ALRT for the Canadian market. It boasts the same specifications and technological achievements as the 1st generation all-in-one model previously announced.
The quantity of CGM units required for the US and EU markets dictates that ALRT and its distributor defer the launch until the new 2nd generation all-in-one model is available from the Company’s CGM hardware supplier. At which time, the Company will be well positioned to meet market demand with reduced delivery lead-times and significant production availability. GluCurve featuring the all-in-one model CGM hardware will replace the interim two piece model in Canada concurrent with the US and EU launch.
About ALR Technologies SG Ltd.
ALRT is a data management company that developed the ALRT Diabetes Solution, a comprehensive approach to diabetes care that includes an FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and a patent pending Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. The overall goal is to optimize diabetes drug therapies to drive improved patient outcomes.
In addition, the animal health division of ALRT has developed the GluCurve Pet CGM; a solution to assist veterinarians better determine the efficacy of insulin treatments and to help to identify the appropriate dose and frequency of administration for companion animals, thereby delivering the same optimization of diabetic drug therapies to pets as to humans.
More information about ALRT and the GluCurve Pet CGM can be found at https://www.alrt.com and https://www.glucurve.com/Index.
Sure hope ALRT makes their planned Q3 shipment of their 2nd Gen GluCurve, it's successful, and we get some positive PR's and exposure. The share price on this is abysmal and stuck in neutral for way too long. GLTUA
Although CGM is important to diabetes care the thing that separates ALRTF from all others is the value added feature (patented, internationally protected) Predictive A1C. Are we too focused on CGM and losing sight of the real prize?
Senseionics has an implantable CGM that requires minor surgery to place under the skin, and then a transmitter has to be attached overtop the skin to transmitter the readings to a phone. It has a ton of problems for humans and even more so for animal use. I dont have it handy but I remember reading a study that was done with it on animals and that did not go well, I believe a number of units stopped working or got lost in the skin.
Senseionics implantable CGMs will never catch on for use in humans or animals in my opinion. They are also thousands of dollars each/
Didnt see anything about animal use for sensionics cgm, will keep watching
Looks like we have competition. SENSionics HAS A CGM
Thanks for Sharing the message gopher. You have been good about reaching out to investor relations. Hopefully the updates and good news starts rolling in.
Gltu as well McVee. Still think this one is going to work out for us.
Here is the response I received from Investors Relations asking about company updates...
We hope to put out another update in the coming weeks and if things go as planned I would expect a constant stream of updates going forward. Unfortunately things have taken much longer then we initially anticipated and we have had to overcome several challenges along the way, but I believe we have a better product and better business strategy because of it.
I am personally quite excited for the coming months as a lot of hard work has gone into getting us to where we are now and I believe we’ll finally be able to reap the benefits of our efforts. We greatly appreciate our loyal shareholders and are diligently working to bring them value even if we are not able to publicly announce all of our plans or efforts at this time.
V/r
Joe Stern
Head of Animal Health
johnglenn - not sure why my comments would bother anyone. In roughly 6 years holding this, I certainly get a little frustrated with the progress made. But, I don't malign Chan, the company, nor it's executive staff - as some have done over the years that are no longer.
I just don't get all pumped up with fantasy predictions about "dollar land" coming any day now, or the rest of the usual hype I've seen. This was a speculative investment in a company and penny stock that appeared to have a good product well before GluCurve and animal A1C monitoring came about. Just hoping it wouldn't take 10 years to come to fruition. Still hoping! GLTU.
johnglennn, no. Still holding. And that's 250K shares, not 280K.
If retail doesn't sell, the market makers will sell into those bids and take it for themselves.
Mcvee did you sell 280k shares?
$18,000 dollar value bidder! Extremely large!
Mcvee's comments have never really bothered me, he is free to post whatever he wants.
But, it is worth noting that anyone of us can sell up to 400k shares right now for at least .045.
If anyone needs to pay the bills, today is the day.
If the bids would up the offer a bit we could blast through the 5's and get back to 6's and 7's.
Be a tortoise because they live a long time?
Nice bid at .045, haven't had a big that large in a while.
Patience please. The finish line is in sight. Be the tortoise, not the hare.
... for the last 6 years! LOL
Good. Because this has been dead money for years now.
Anytime now we will hear about GC2.
Welp,getting very close to third quarter and Glucurve 2. This is money dude!$$$$$$$
fawk no... any technical traders have a take on this ticker?
Did anyone here get those $0.0211 shares filled?
Date/Time Price Shares Exch/Mkt
06/22/2023 15:25:07 EDT 0.03675 3000 OTCBB
06/22/2023 15:00:04 EDT 0.035 46100 OTCBB
06/22/2023 15:00:01 EDT 0.035 10000 OTCBB
06/22/2023 11:07:04 EDT 0.035 33900 OTCBB
06/22/2023 11:06:57 EDT 0.035 10000 OTCBB
$$$$$ 06/22/2023 10:38:58 EDT 0.0211 108500 OTCBB *$$$$$$******
06/22/2023 10:38:55 EDT 0.031 10000 OTCBB
06/22/2023 10:38:45 EDT 0.034 10000 OTCBB
06/22/2023 10:38:21 EDT 0.034 21500 OTCBB
06/21/2023 10:58:37 EDT 0.037 10000 OTCBB
06/21/2023 10:57:46 EDT 0.0355 10000 OTCBB
06/21/2023 10:57:16 EDT 0.034 10000 OTCBB
06/21/2023 10:27:10 EDT 0.0425 5000 OTCBB
06/21/2023 10:26:47 EDT 0.0425 10000 OTCBB
06/20/2023 9:30:09 EDT 0.04 4000 OTCBB
06/16/2023 15:53:03 EDT 0.037 7000 OTCBB
Abbott Recalls the Readers used with the FreeStyle Libre, FreeStyle Libre 14 day, and FreeStyle Libre 2 Flash Glucose Monitoring Systems for Risk of Extreme Heat and Fire. This is the ones veterinarians are using hopefully will start using Glucurve
Volume and dollar amount traded has been next to none, but L2 shows 10k at .0425, 110k shares at .05, then 220k at .07 so if any real volume comes through we'll be right back to the .07+ mark...
Never thought it would be difficult to shore this up at .035 but got the majority of my 100k shares filled.. not sure why all the selling
Interesting. I guess we'll what gets developed.
Right. But TD is no longer. Got bought out by Schwab.
If you're talking about OTCmarkets_dot_com, yeah. Been there but it is 15 min delayed. With the old TD Ameritrade, you used to be able to see buy/sell order being filled in real time, plus indeividual MM's bid/ask prices and lot sizes. Then, for some reason TD stopped providing that feature. Now, I don't even see Level II on Schwab. You can click on the stock of interest and see Bid/Ask price and qty, but not by MM and certainly not real time transactions.
Anyway, I'm not real another slow day in ALRTF trades. 117 shares so far today. Jeesh.
GLTU
Good catch. I signed up for the newsletter. I hope they don't mind, but I want updates. Hopefully a Canada pr soon. Thanks...
Ran across this today. Interesting -- GluCurve.ca -- registered - hopefully some news from Canada soon.
fwiw i have td ameritrade/schwab and fidelity.
fidelity is $0 fee and free L2.
glta
I had both. I agree, td was better. The last order filled witha fee of 6.95. No fee for foreign, seems it is the same as td now.
Haven't done much with schwab, I liked the level 2 on td.
To check bid and ask I go to the OTC markets site and search alrtf.
Yeah. I see that. I also had TD Ameritrade as my brokerage and now am with Schwab, but I didn't know they fooked us on trades with tickers ending in an "F". I'll keep that in mind. Yes. They are Rat Bastards. And to be honest, I don't like their platform as much. BTW, where do you see Level II on Schwab?
I take back all the mean things I said about schwab. Just place an order, no fifty dollar f fee.
My order from yesterday expired. I will put another in that also won't fill. The price only drops to fill other people's orders.
Td ameritrade transferred to schwab. Those rat bastards have a $50 fee for tickers with an F.
Might want to cancel that order and put an order in for 03. GLTU!
Don't worry guys. I put a buy in at .0375. So we are guaranteed not to drop below .04. You are welcome.
2nd generation sounds like a nice improvement. Size improvement alone is a nice upgrade.
Was it mentioned anywhere who the new manufacturer is?
I would just throw 50k out there and see what happens.
Followers
|
148
|
Posters
|
|
Posts (Today)
|
3
|
Posts (Total)
|
13179
|
Created
|
10/05/09
|
Type
|
Free
|
Moderators |
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |